18.02.2022 | 2022 Satellite Meeting: Drug Discovery for Ion Channels XXII
Conference Venue: Esplanade, Room 153, Moscone Center, San Francisco, California, USA
Go to the Conference website here
Nanion is a proud sponsor of next year's Satellite Meeting of the BPS
Registration site is available here
Agenda
8:00 - 8:30 AM
Registration and Coffee
8:30 - 8:45 AM
Niels Fertig, Nanion Technologies, Germany
Welcome and Opening Remarks
Session I Chair: Daniel Sauter, Sophion Bioscience, Denmark
08:45 - 09:30 AM
Keynote Speaker: Henry Colecraft, Columbia University, USA
Title: "Regulating Ion Channel Functional Expression and Gating with Engineered Nanobodies"
09:30 - 10:00 AM
Robert Kirby, Metrion Biosciences, United Kingdom
Title: "Development of a Current-Clamp Assay as a Physiologically Relevant Screen for Kv1.3"
10:00 - 10:30 AM
Fitzwilliam Seibertz, University of Göttingen, Germany
Title: "High Performance Characterization of Atrial Cardiomyocytes"
10:30 - 11:00 AM
Coffee Break
Session II Chair: Ali Yehia, Fluxion Biosciences, USA
11:00 - 11:30 AM
Mohammad-Reza Ghovanloo, Yale University, USA
Title: "Inhibition of Sodium Conductance by Cannabigerol Contributes to a Reduction of Neuronal Dorsal Root Ganglion Excitability"
11:30 - 12:00 PM
Ciria Hernandez, University of Michigan, USA
Title: "High-throughput Functional Evaluation of Melanocortin Compounds in the MC4R-Kir7.1 Complex: Biased Signaling at the Melanocortin Receptor 4"
12:00 - 12:30 PM
Eric Wang, University of Florida, USA
Title: "Cell Lines to Facilitate Studies of GABA Receptor Subunit Combinations"
12:30 - 1:30 PM
Lunch (Provided)
Session III Chair: Niels Fertig, Nanion Technologies, Germany
1:30 - 2:00 PM
Arpad Mike, Eötvös Loránd University, Hungary
Title: "An Investigation of Sodium Channel Blocker Distribution Dynamics Using the Ionflux Mercury: Why Onset is Not Association, Offset is Not Dissociation, and Block is Not Really Block?"
2:00 - 2:30 PM
Sam Goodchild, Xenon Pharmaceuticals, Canada
Title: "NaV1.1 Selective Potentiators Normalize Inhibition/Excitation Imbalance and Prevent Seizures in a Mouse Model of Dravet Syndrome"
2:30 - 3:00 PM
David Dalrymple, SB Drug Discovery, United Kingdom
Title: "Development of a Screening Cascade for Identification of TMEM175 Modulators"
3:00 - 3:30 PM
Coffee Break
Session IV Chair: Robert Kirby, Metrion Biosciences, United Kingdom
3:30 - 3:55 PM
Kris Kahlig, Praxis Precision Medicines, USA
Title to Come
3:55 - 4:20 PM
Andrea Fleig, University of Hawaii, USA
Title: "Natural Products as Modulators of Calcium Signaling in Inflammation"
4:20 - 4:45 PM
Andrew Jenkins, Emory University, USA
Title: "Using Electrophysiology as a Translational Tool in the Ohmic Era"
4:45 - 5:10 PM
Paul Slesinger, Icahn School of Medicine at Mount Sinai, USA
Title: "Targeting GIRK Potassium Channels for Treating Alcoholism"
5:10 - 5:15 PM
Daniel Sauter, Sophion Bioscience, Denmark
Closing Remarks